Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza Vaccine Effectiveness”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07420985
What this trial is testing

Study to Evaluate the Efficacy, Safety, and Tolerability of the Ingavirin Forte Capsules (Valenta Pharm JSC) at Different Doses in Subjects With Influenza and Other Acute Respiratory Viral Infections.

Who this might be right for
InfluenzaAcute Respiratory Viral Infection
Valenta Pharm JSC 300
Not applicableStudy completedNCT01764152
What this trial is testing

Clinical Trial to Assess the Influenza Vaccination (FLUVAC 02)

Who this might be right for
Adult Hospitalized
Institut National de la Santé Et de la Recherche Médicale, France 450
Not applicableUnknownNCT01053533
What this trial is testing

A Pragmatic Randomized Controlled Trial of Chinese Herbal Medicine for Severe Pandemic H1N1 Influenza

Who this might be right for
Influenza A Virus, H1N1 Subtype
Beijing Ditan Hospital 1,100
Testing effectiveness (Phase 2)WithdrawnNCT03028909
What this trial is testing

Dose Ranging Study to Evaluate the Efficacy and Safety of MEDI8852 in Adults Who Are Hospitalized With Type A Influenza.

Who this might be right for
Influenza - Type A Strains
MedImmune LLC
Large-scale testing (Phase 3)Looking for participantsNCT06528444
What this trial is testing

Clinical Trial Evaluating the Efficacy and Safety of Dexamethasone Compared to Placebo in Patients With Severe Influenza

Who this might be right for
Influenza
Instituto de Investigación Sanitaria y Biomédica de Alicante 42
Early research (Phase 1)Study completedNCT02267733
What this trial is testing

Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing In Gammopathy Patients

Who this might be right for
InfluenzaGammopathy
Yale University 51
Large-scale testing (Phase 3)Study completedNCT00979602
What this trial is testing

Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older

Who this might be right for
Influenza
GlaxoSmithKline 4,048
Large-scale testing (Phase 3)Study completedNCT03704740
What this trial is testing

Immunogenicity and Safety of NBP607-QIV Compared to Agrippal in Children Aged 6 to 35 Months

Who this might be right for
Influenza
SK Bioscience Co., Ltd. 676
Large-scale testing (Phase 3)Ended earlyNCT04137887
What this trial is testing

Study to Evaluate the Effectiveness of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Adults 65 Years of Age and Older

Who this might be right for
Influenza (Healthy Volunteers)
Sanofi Pasteur, a Sanofi Company 33,096
Large-scale testing (Phase 3)Study completedNCT02917304
What this trial is testing

Evaluate the Efficacy and Safety of GC3110A in Healthy Subjects Aged 65 Years and Older

Who this might be right for
Influenza, Human
Green Cross Corporation 274
Testing effectiveness (Phase 2)Study completedNCT04441047
What this trial is testing

Universal Anti-Viral Vaccine for Healthy Elderly Adults

Who this might be right for
Virus DiseasesPneumoniaCOVID-19 Respiratory Infection+3 more
Mirror Biologics, Inc. 40
Large-scale testing (Phase 3)Study completedNCT03460743
What this trial is testing

Evaluation of a Recombinant Quadrivalent Influenza Vaccine Versus a Marketed Quadrivalent Inactivated Influenza Vaccine in Children 3 to 17.

Who this might be right for
Influenza, Human
Laboratorios Liomont 1,556
Post-approval studies (Phase 4)Not Yet RecruitingNCT07790523
What this trial is testing

Effectiveness of An Influenza/COVID-19 Vaccine (mCombriax [mRNA-1083]) in Adults ≥ 65 Years

Who this might be right for
COVID-19Influenza
Tor Biering-Sørensen 410,000
Large-scale testing (Phase 3)Study completedNCT06602024
What this trial is testing

MRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age

Who this might be right for
Seasonal Influenza
ModernaTX, Inc. 40,805
Large-scale testing (Phase 3)Study completedNCT00192413
What this trial is testing

Trial to Compare the Safety, Tolerability, and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Inactivated, Influenza Vaccine, Trivalent, Types A & B, in Adults Aged 60 Years and Older Against Culture-confirmed Influenza

Who this might be right for
Influenza
MedImmune LLC 3,009
Large-scale testing (Phase 3)Study completedNCT02285998
What this trial is testing

Protective Efficacy of Flublok® Quadrivalent Versus Licensed Inactivated Influenza Vaccine in Adults ≥50 Years of Age

Who this might be right for
Influenza
Protein Sciences Corporation 9,003
Large-scale testing (Phase 3)Study completedNCT00539981
What this trial is testing

Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok

Who this might be right for
Influenza
Sanofi 4,648
Testing effectiveness (Phase 2)Study completedNCT04706468
What this trial is testing

To Evaluate the Efficacy and Safety of TG-1000 Compared With Placebo in Adult Patients With Acute Uncomplicated Influenza Virus Infection

Who this might be right for
Influenza Virus Infection
TaiGen Biotechnology Co., Ltd. 202
Not applicableStudy completedNCT03694392
What this trial is testing

Flublok v. Standard Dose Vaccine Effectiveness Among Kaiser Permanente Northern California Adults 18-64 Years

Who this might be right for
InfluenzaPneumoniaLower Respiratory Tract Infection+3 more
Kaiser Permanente 2,776,278
Not applicableUnknownNCT06486766
What this trial is testing

Effectiveness of SMS Nudging to Increase Coverage of Influenza Vaccination Among the Elderly

Who this might be right for
Influenza
Norwegian Institute of Public Health 1,000,000
Next Page